Ziprasidone
Zypsila belongs to a group of medicines called antipsychotics.
Zypsila is used to treat schizophrenia in adults - a mental disorder characterized by the following symptoms: seeing, hearing, or feeling things that do not exist, believing in unreal things, excessive suspiciousness, withdrawal or difficulty in contacting others, nervousness, depression, or anxiety.
Zypsila is also used in adults and children and adolescents aged 10-17 years for the treatment of manic or mixed episodes of moderate severity in bipolar affective disorders - mental disorders characterized by variable states of elevated (mania) or lowered (depression) mood. The most characteristic symptoms of a manic episode are: excessive excitement, elevated self-esteem, increased energy, decreased need for sleep, difficulty concentrating, or hyperactivity and repetitive behaviors with high risk.
Before starting treatment with Zypsila, you should discuss it with your doctor or pharmacist.
The safety and efficacy of ziprasidone in the treatment of schizophrenia in children and adolescents have not been established.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take, including those available without a prescription.
DO NOT TAKE Zypsilaif you are taking medicines used to treat heart rhythm disorders or that may affect heart function, such as:
Before starting treatment with Zypsila, you should discuss it with your doctor or pharmacist.
You should tell your doctor or pharmacist about any medicines you are currently taking or have recently taken, including:
See also the section "When not to take Zypsila".
Zypsila SHOULD BE TAKEN WITH MAIN MEALS.
You should not drink alcohol while taking Zypsila, as it increases the risk of side effects.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor before taking this medicine.
Pregnancy
Zypsila should not be taken during pregnancy, unless your doctor advises otherwise, as there is a risk of fetal harm.
In newborns whose mothers take Zypsila in the last 3 months of pregnancy, the following symptoms may occur: trembling, muscle stiffness, and (or) weakness, drowsiness, excitement, breathing difficulties, feeding difficulties. If your baby experiences any of these symptoms, you should contact your doctor immediately.
Breastfeeding
You should not breastfeed while taking Zypsila, as small amounts of the medicine may be excreted in breast milk.
Contraception
If you can become pregnant while taking this medicine, you should use effective contraception.
Zypsila may cause drowsiness. If you experience drowsiness, you should not drive, operate machinery, or perform other potentially hazardous activities until it resolves.
If you have been diagnosed with an intolerance to some sugars, you should contact your doctor before taking this medicine.
This medicine should always be taken exactly as advised by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
The capsules should be taken with food and swallowed whole, without chewing, crushing, or opening. It is important not to chew, crush, or open the capsules, as this may affect the amount of medicine absorbed in the gut.
Zypsila should be taken twice a day - one capsule in the morning, with a hearty breakfast, and one capsule in the evening, with dinner. The medicine should be taken at the same time every day.
The recommended dose is 40 to 80 mg, twice a day, taken with food.
In the case of long-term treatment, your doctor may adjust the dose of the medicine. Do not exceed the maximum dose of 160 mg per day.
The recommended initial dose is 20 mg, taken with food. Then, your doctor will determine the optimal dose for your child. Do not exceed the maximum dose of 80 mg per day in children with a body weight of less than 45 kg or 160 mg per day in children with a body weight of 45 kg or more.
The safety and efficacy of ziprasidone in the treatment of schizophrenia in children and adolescents have not been established.
In elderly patients, your doctor will determine the dose suitable for you. In patients over 65 years old, the doses of the medicine are often lower than those used in younger patients. Your doctor will inform you about the dose that is right for you.
In patients with liver function disorders, it may be necessary to use a lower dose of Zypsila. Your doctor will determine the suitable dose for you.
You should contact your doctor or go to the nearest hospital emergency department immediately. You should take the packaging of Zypsila with you.
If you take a higher dose of Zypsila than recommended, you may experience symptoms such as drowsiness, trembling, seizures, and involuntary movements of the head and neck.
It is important to take Zypsila regularly, at the same time every day. If you forget to take a dose, you should take it as soon as you remember, unless it is time for your next dose. In this case, you should take the next dose. Do not take a double dose to make up for the missed dose.
Your doctor will inform you about how long you should take Zypsila. You should not stop taking Zypsila unless your doctor decides to.
It is important to continue taking the medicine, even if you feel better. If treatment is stopped too early, the symptoms of the disease may return.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most side effects are temporary. Sometimes it can be difficult to distinguish the symptoms of the disease itself from the side effects.
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1000 people):
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1000 people):
Unknown frequency (cannot be estimated from the available data):
In clinical trials with children and adolescents, side effects were generally similar to those in adults (see above), except for sedation (calmness) and drowsiness, which occurred more frequently in children. The most common side effects in children and adolescents were sedation, drowsiness, headache, fatigue, nausea, dizziness, vomiting, decreased appetite, and movement disturbances.
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not store above 30°C.
Store in the original packaging to protect from moisture.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
20 mg, hard capsules
The capsule cap is pale green, and the capsule body is white. The capsule contains a powder that is pinkish-brown in color.
40 mg, hard capsules
The capsule cap is dark green, and the capsule body is pale green. The capsule contains a powder that is pinkish-brown in color.
60 mg, hard capsules
The capsule cap is dark green, and the capsule body is white. The capsule contains a powder that is pinkish-brown in color.
80 mg, hard capsules
The capsule cap is pale green, and the capsule body is white. The capsule contains a powder that is pinkish-brown in color.
Pack sizes: 28, 30, 56, 60, or 90 hard capsules in blisters, in a cardboard box.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Austria | Ziprasidon Krka |
Bulgaria | Zypsila 20 (40/60/80) |
Czech Republic | Zypsilan 20 (40/60/80) mg |
Denmark | Ziprasidon Krka |
Estonia | Ypsila |
Finland | Ziprasidon Krka |
Germany | Zipsilan 20 (40/60/80) mg Hartkapseln |
Hungary | Ypsila 20 (40/60/80) |
Lithuania | Zypsilan 20 (40/60/80) |
Latvia | Ypsila 20 (40/60/80) mg cietās kapsulas |
Poland | Zypsila |
Slovenia | Zypsila 20 (40/60/80) |
Slovakia | Zypsilan |
Spain | Ziprasidona Krka |
Sweden | Ziprasidon Krka |
Romania | Zypsila 20 (40/60/80) mg |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.